Ciletatug
Based on 1 Customer Validation
Ciletatug (RC118 Antibody) is a humanized IgG1κ antibody targeting CLDN18.2. Ciletatug can be used as an ADC antibody to synthesize the ADC molecule RC118. RC118 can be used for research on locally advanced unresectable or metastatic malignant solid tumors. The corresponding isotype control for Ciletatug is: Human IgG1 kappa, Isotype Control (HY-P99001).
For research use only. We do not sell to patients.
- Purity : 96.53%
- CAS No.: 2897622-41-0
- Molecular Weight:146.41 kDa
-
Storage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
[2]|
CLDN18.2 |
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Gene ID
Accession
Conjugated
Unconjugated
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
IgG1-kappa
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized Claudin-18/CLDN18.2 Protein-VLP, Human (HY-P78368) can bind Ciletatug. The EC50 for this effect is 6.369 ng/mL.
Chemical Information
-
CAS No. 2897622-41-0
-
Appearance Liquid
-
Molecular Weight 146.41 kDa
-
Color Colorless to light yellow
-
SMILES
[Ciletatug]
-
Synonyms
RC118 Antibody
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (269 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)